Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Wilms Tumor 1Peripheral Nervous System Diseases 1Osteosarcoma 1Neurotoxicity Syndromes 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Liposarcoma 1Leukemia 1Kidney Neoplasms 1Hemangiosarcoma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Dendritic Cell Sarcoma, Interdigitating 1Chondrosarcoma 1Burkitt Lymphoma 1

Interventions

Radiotherapy 10Doxorubicin 10Ifosfamide 9Vincristine 8Filgrastim 8Cyclophosphamide 8Dactinomycin 7Etoposide 5Carboplatin 4sargramostim 3Irinotecan 3Trabectedin 2Topotecan 2Radiotherapy, Conformal 2Neoadjuvant Therapy 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Epirubicin 2Chemotherapy, Adjuvant 2trioctyl phosphine oxide 1romidepsin 1pegfilgrastim 1indolepropanol phosphate 1etoposide phosphate 1cixutumumab 1brostallicin 1Watchful Waiting 1Vinorelbine 1Temozolomide 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant mesenchymal tumor × Glutamine × Sarcoma × Clear all
NCT00334984 2013-07-11

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Children's Oncology Group

Phase NA Withdrawn
Sarcoma

Malignant mesenchymal tumor, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Dermatofibrosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡